Parallel Advisors, LLC Solid Biosciences Inc. Transaction History

Parallel Advisors, LLC

$4.18 Billion
Q3 2024

A detailed history of Parallel Advisors, LLC transactions in Solid Biosciences Inc. stock. As of the latest transaction made, Parallel Advisors, LLC holds 7 shares of SLDB stock, worth $37. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Previous 7 -0.0%

Holding current value

$37

Previous $0 NaN%

% of portfolio

0.0%

Previous 0.0%

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	BUY	$5.67 - $12.52 $5 - $12	1 Added 16.67%	7 $0
Q4 2022 Feb 03, 2023	SELL	$5.27 - $7.65 $495 - $719	-94 Reduced 94.0%	6 $0
Q1 2022 Apr 28, 2022	BUY	$0.74 - $1.79 $74 - $179	100 New	100 $0
Q4 2021 Jan 20, 2022	SELL	$1.69 - $2.46 $491 - $715	-291 Closed	0 $0
Q3 2021 Nov 02, 2021	BUY	$2.38 - $3.77 $692 - $1,097	291 New	291 $1,000

Others Institutions Holding SLDB

# of Institutions

Shares Held

Call Options Held

Put Options Held

Corsicana & Co.

90
Shares

$484
0.0% of portfolio

View Full List

About Solid Biosciences Inc.

Ticker SLDB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 7,533,080
Market Cap $40.5M
Description
Solid Biosciences Inc. engages in developing therapies for duchenne muscular dystrophy in the United States. The company's lead product candidate is SGT-001, a gene transfer candidate, which is in a Phase I/II clinical trial to drive functional dystrophin protein expression in patients' muscles; and SGT-003, a ext-generation gene transfer candid...

More about SLDB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallel Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parallel Advisors, LLC with notifications on news.

Account

Parallel Advisors, LLC Solid Biosciences Inc. Transaction History